Stockreport

UK Approves Higher Wegovy Dose for Obesity; Novo Nordisk Shares Rise 3% [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Regulatory Agency approved a higher 7.2 milligram weekly dose of its weight-loss medicine Wegovy for individuals who are overweight.Patients with a body mass index of 30 [Read more]